- Home
- ARR vs ANIP Comparison
ARR vs ANIP Comparison
Compare ARR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARR
- ANIP
- Stock Information
- Founded
- ARR 2008
- ANIP 2001
- Country
- ARR United States
- ANIP United States
- Employees
- ARR N/A
- ANIP N/A
- Industry
- ARR Real Estate Investment Trusts
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- ARR Real Estate
- ANIP Health Care
- Exchange
- ARR Nasdaq
- ANIP Nasdaq
- Market Cap
- ARR 1.1B
- ANIP 1.2B
- IPO Year
- ARR N/A
- ANIP N/A
- Fundamental
- Price
- ARR $18.89
- ANIP $57.94
- Analyst Decision
- ARR Hold
- ANIP Buy
- Analyst Count
- ARR 3
- ANIP 7
- Target Price
- ARR $21.00
- ANIP $77.33
- AVG Volume (30 Days)
- ARR 2.5M
- ANIP 172.8K
- Earning Date
- ARR 02-12-2025
- ANIP 02-28-2025
- Dividend Yield
- ARR 15.25%
- ANIP N/A
- EPS Growth
- ARR N/A
- ANIP N/A
- EPS
- ARR N/A
- ANIP N/A
- Revenue
- ARR $39,256,000.00
- ANIP $555,456,000.00
- Revenue This Year
- ARR N/A
- ANIP $25.54
- Revenue Next Year
- ARR $43.24
- ANIP $20.95
- P/E Ratio
- ARR N/A
- ANIP N/A
- Revenue Growth
- ARR N/A
- ANIP 23.60
- 52 Week Low
- ARR $17.35
- ANIP $52.50
- 52 Week High
- ARR $21.93
- ANIP $70.81
- Technical
- Relative Strength Index (RSI)
- ARR 51.10
- ANIP 46.25
- Support Level
- ARR $18.60
- ANIP $58.37
- Resistance Level
- ARR $19.25
- ANIP $60.54
- Average True Range (ATR)
- ARR 0.28
- ANIP 1.69
- MACD
- ARR 0.01
- ANIP -0.21
- Stochastic Oscillator
- ARR 63.64
- ANIP 20.28
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.